台股 » 旭富 » 個股財報 » 毛利成長率(年增率)
- 股價
93.9
- 漲跌
▲1.4
- 漲幅
+1.51%
- 成交量
546張
- 產業
上市 生技醫療類股
▲2.79%
-
本地時間:14:30(已收盤)
旭富 (4119) 財務報表－毛利成長率(年增率)
毛利成長率
毛利季增率 = (毛利÷上季毛利)-1。
毛利年增率 = (毛利÷去年同季毛利)-1。
旭富 (4119) 歷年毛利年增率
| 年度/季別 | 毛利年增率 | 近4季毛利年增率 | 年度/季別 | 毛利年增率 | 近4季毛利年增率 |
|---|
| 2024Q1 | -25.31% | -11.1% | 2021Q2 | -90.93% | -42.93% |
| 2023Q4 | -18.7% | 20.31% | 2021Q1 | -73.26% | -1.66% |
| 2023Q3 | -13.86% | 72.78% | 2020Q4 | 32.33% | 36.18% |
| 2023Q2 | 32.78% | 96.34% | 2020Q3 | 21.22% | 30.25% |
| 2023Q1 | 123% | 114.46% | 2020Q2 | 55.55% | 30.45% |
| 2022Q4 | 2301.42% | 39.93% | 2020Q1 | 35.09% | 16.58% |
| 2022Q3 | 25.4% | -50.83% | 2019Q4 | -0.12% | 24.95% |
| 2022Q2 | 73.65% | -70.99% | 2019Q3 | 20.25% | 35.97% |
| 2022Q1 | -42.44% | -83.45% | 2019Q2 | 4.52% | 55.36% |
| 2021Q4 | -98.47% | -83.67% | 2019Q1 | 101.4% | 106.87% |
| 2021Q3 | -75.94% | -64.68% | | | |
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨－2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨－2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨－2022/11/23